Share this article
Share this article
NEW YORK, Aug. 3, 2021 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Scholar Rock Holding Corporation ( Scholar Rock or the Company ) (NASDAQ: SRRK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
The investigation concerns whether Scholar Rock and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On August 3, 2021, Scholar Rock issued a press release announcing the abrupt departure of Company President and Chief Executive Officer Tony Kingsley, who had served in both roles since August 2020, without providing any explanation.
Share this article
Share this article
NEW YORK, Aug. 3, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Ocugen, Inc. ( Ocugen or the Company ) (NASDAQ: OCGN) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 21-cv-03182, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Ocugen securities between February 2, 2021, and June 10, 2021, inclusive (the Class Period ), seeking to recover damages for violations of the federal securities laws under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ), and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Share this article
Share this article
NEW YORK, Aug. 3, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against 360 DigiTech, Inc. ( 360 DigiTech , or the Company ) (NASDAQ: QFIN) and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 21-cv-06013, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired 360 DigiTech securities between April 30, 2020 and July 7, 2021, both dates inclusive (the Class Period ), seeking to recover damages caused by Defendants violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Message :
Required fields
NEW YORK, Aug. 4, 2021 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Coinbase Global, Inc. ( Coinbase or the Company ) (NASDAQ: COIN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.
The investigation concerns whether Coinbase and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On May 17, 2021, Coinbase announced a $1.25 billion convertible bond sale.
Forbes.com noted that [i]nvestors were also likely surprised by the timing of the issue, considering that Coinbase just went public in mid-April via a direct listing (which doesn t involve issuing new shares or raising capital), signaling that it didn t require cash. On this news, Coinbase s stock price fell $9.24 per share, or 3.7%, to close at $239.00 per share on May 18, 2021. Then, on May 19, 2021, Coinbase announced tech
Share this article
Share this article
NEW YORK, Aug. 3, 2021 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of. Athira Pharma, Inc. ( Athira or the Company ) (NASDAQ: ATHA). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
The investigation concerns whether Athira and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On or around September 18, 2021, Athira conducted its initial public offering ( IPO ), selling 12 million shares priced at $17.00 per share. Then, on June 17, 2021, Athira announced that the Company s board had placed its President and Chief Executive Officer, Leen Kawas, on temporary leave pending an investigation of actions stemming from doctoral research Dr. Kawas conducted while at Washington State University.